4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $3.05M in the quarter ending March 31, 2026, with 21,664.29% growth. This brings the company's revenue in the last twelve months to $88.24M, up 383,560.87% year-over-year. In the year 2025, 4D Molecular Therapeutics had annual revenue of $85.21M with 230,194.59% growth.

• Revenue (ttm): $88.24M
• Revenue Growth: +383,560.87%
• P/S Ratio: 6.17
• Revenue / Employee: $450,214
• Employees: 196
• Market Cap: 544.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.21M	85.17M	230,194.59%
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	8.34M	144.04%
Dec 31, 2017	5.79M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error